Ra. Cowles et Mw. Mulholland, Surgical management of peptic ulcer disease in the helicobacter era-management of bleeding peptic ulcer, SURG LA E P, 11(1), 2001, pp. 2-8
Bleeding continues to be a significant cause of morbidity and mortality for
patients with peptic ulcer disease. Recent advances have changed the manag
ement of this disease. Upper endoscopy with or without endoscopic therapy i
s the preferred procedure during the initial evaluation of upper gastrointe
stinal bleeding. With its excellent success rates, many patients are being
cured with endoscopic therapy followed by eradication of Helicobacter pylor
i. H. pylori is now thought to have an important role in the pathogenesis o
f a majority of gastric and duodenal ulcers. This finding has led to the re
commendation that patients with peptic ulcer disease be treated with regime
ns effective against this organism. Currently, patients who are older and w
ho have more severe underlying medical conditions present a challenge. This
review will address the options for treatment of peptic ulcer bleeding. In
addition, knowledge gained regarding H. pylori infection and use of nonste
roidal anti-inflammatory drugs will be discussed.